Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell cycle progression machinery related to S-phase arrest encompasses a network of proteins and regulatory complexes that control the orderly progression of cells through the S-phase, dedicated to DNA synthesis. S-phase arrest halts DNA replication, preventing cell division. Key components include cyclins (E, A), cyclin-dependent kinases (CDKs), CDK inhibitors (CKIs) like p21 and p27, and E2F transcription factors. Mechanisms leading to S-phase arrest involve the DNA damage response, the p53 pathway, and pharmacological induction. Arresting cells in S phase prevents the propagation of damaged genomes and is exploited therapeutically by anti-cancer agents that trigger irreversible arrest leading to apoptosis. Targeting cyclins/CDKs or their regulators is a strategy for cancer therapy.
Inhibition of CDKs; activation of checkpoint kinases; induction of CKIs
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Cycle Progression Machinery (S-phase Arrest).